Literature DB >> 17486143

Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor.

R J Bailey1, D L Hay.   

Abstract

BACKGROUND AND
PURPOSE: Transmembrane proline (P) residues in family A G protein-coupled receptors (GPCRs) form functionally important kinks in their helices. These residues are little studied in family B GPCRs but experiments with the VPAC1 receptor and calcitonin receptor-like receptor (CL) show parallels with family A receptors. We sought to determine the function of these residues in the insert negative form of the human calcitonin receptor, a close relative of CL. EXPERIMENTAL APPROACH: Proline residues within the transmembrane domains of the calcitonin receptor (P246, P249, P280, P326, P336) were individually mutated to alanine (A) using site-directed mutagenesis. Receptors were transiently transfected into Cos-7 cells using polyethylenimine and salmon and human calcitonin-induced cAMP responses measured. Salmon and human calcitonin competition binding experiments were also performed and receptor cell-surface expression assessed by whole cell ELISA. KEY
RESULTS: P246A, P249A and P280A were wild-type in terms of human calcitonin-induced cAMP activation. P326A and P336A had reduced function (165 and 12-fold, respectively). In membranes, human calcitonin binding was not detectable for any mutant receptor but in whole cells, binding was detected for all mutants apart from P326A. Salmon calcitonin activated mutant and wild-type receptors equally, although B(max) values were reduced for all mutants apart from P326A. CONCLUSIONS AND IMPLICATIONS: P326 and P336 are important for the function of human calcitonin receptors and are likely to be involved in generating receptor conformations appropriate for agonist binding and receptor activation. However, agonist-specific effects were observed , implying distinct conformations of the human calcitonin receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486143      PMCID: PMC2013989          DOI: 10.1038/sj.bjp.0707246

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

Review 1.  Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.

Authors:  U Gether
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

2.  The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists.

Authors:  C Watson; G Chen; P Irving; J Way; W J Chen; T Kenakin
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

Review 4.  International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.

Authors:  David R Poyner; Patrick M Sexton; Ian Marshall; David M Smith; Remi Quirion; Walter Born; Roman Muff; Jan A Fischer; Steven M Foord
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

5.  Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations.

Authors:  Alessandro Bisello; Michael Chorev; Michael Rosenblatt; Luca Monticelli; Dale F Mierke; Serge L Ferrari
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

6.  Pharmacology of the human CGRP1 receptor in Cos 7 cells.

Authors:  Richard J Bailey; Debbie L Hay
Journal:  Peptides       Date:  2005-12-20       Impact factor: 3.750

7.  A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein.

Authors:  H H Versteeg; E Nijhuis; G R van den Brink; M Evertzen; G N Pynaert; S J van Deventer; P J Coffer; M P Peppelenbosch
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

8.  Functional roles of conserved transmembrane prolines in the human VPAC(1) receptor.

Authors:  S M Knudsen; J W Tams; J Fahrenkrug
Journal:  FEBS Lett       Date:  2001-08-17       Impact factor: 4.124

9.  The critical role of transmembrane prolines in human prostacyclin receptor activation.

Authors:  Jeremiah Stitham; Kathleen A Martin; John Hwa
Journal:  Mol Pharmacol       Date:  2002-05       Impact factor: 4.436

10.  The evolution of transmembrane helix kinks and the structural diversity of G protein-coupled receptors.

Authors:  Sarah Yohannan; Salem Faham; Duan Yang; Julian P Whitelegge; James U Bowie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

View more
  13 in total

1.  The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.

Authors:  Kenji Kuwasako; Debbie L Hay; Sayaka Nagata; Tomomi Hikosaka; Kazuo Kitamura; Johji Kato
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.

Authors:  Denise Wootten; John Simms; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 3.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

Review 4.  Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

Authors:  James Barwell; Joseph J Gingell; Harriet A Watkins; Julia K Archbold; David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

5.  Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT((a)) function.

Authors:  T Qi; M Dong; H A Watkins; D Wootten; L J Miller; D L Hay
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies.

Authors:  Shabana Vohra; Bruck Taddese; Alex C Conner; David R Poyner; Debbie L Hay; James Barwell; Philip J Reeves; Graham J G Upton; Christopher A Reynolds
Journal:  J R Soc Interface       Date:  2012-12-12       Impact factor: 4.118

7.  Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.

Authors:  Harriet A Watkins; Madhuri Chakravarthy; Rekhati S Abhayawardana; Joseph J Gingell; Michael Garelja; Meenakshi Pardamwar; James M W R McElhinney; Alex Lathbridge; Arran Constantine; Paul W R Harris; Tsz-Ying Yuen; Margaret A Brimble; James Barwell; David R Poyner; Michael J Woolley; Alex C Conner; Augen A Pioszak; Christopher A Reynolds; Debbie L Hay
Journal:  J Biol Chem       Date:  2016-03-24       Impact factor: 5.157

8.  The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach.

Authors:  Michael J Woolley; Harriet A Watkins; Bruck Taddese; Z Gamze Karakullukcu; James Barwell; Kevin J Smith; Debbie L Hay; David R Poyner; Christopher A Reynolds; Alex C Conner
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

9.  Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.

Authors:  H A Watkins; C S Walker; K N Ly; R J Bailey; J Barwell; D R Poyner; D L Hay
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology.

Authors:  Joseph J Gingell; John Simms; James Barwell; David R Poyner; Harriet A Watkins; Augen A Pioszak; Patrick M Sexton; Debbie L Hay
Journal:  Cell Discov       Date:  2016-05-17       Impact factor: 10.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.